Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.
Poston JN, Bryan C, von Drygalski A, Al Banaa K, Zhou JY, Parnes A, Chen EC, Khan O, Ellsworth P, Cafuir L, Walsh C, Escobar MA, Wu JF, Malec LM, Kessler CM, Janbain M, Kruse-Jarres R. Poston JN, et al. Among authors: kruse jarres r. Blood Adv. 2024 Nov 26;8(22):5896-5905. doi: 10.1182/bloodadvances.2024013882. Blood Adv. 2024. PMID: 39361769 Free PMC article.
Acquired hemophilia A: emerging treatment options.
Janbain M, Leissinger CA, Kruse-Jarres R. Janbain M, et al. J Blood Med. 2015 May 8;6:143-50. doi: 10.2147/JBM.S77332. eCollection 2015. J Blood Med. 2015. PMID: 26056504 Free PMC article. Review.
Advances in Acquired Hemophilia A.
Poston JN, Kruse-Jarres R. Poston JN, et al. Transfus Med Rev. 2022 Oct;36(4):215-219. doi: 10.1016/j.tmrv.2022.07.001. Epub 2022 Sep 7. Transfus Med Rev. 2022. PMID: 36280447
Emicizumab for hemophilia A without inhibitors.
Cafuir L, Kruse-Jarres R, Mancuso ME, Kempton CL. Cafuir L, et al. Expert Rev Hematol. 2019 Jul;12(7):515-524. doi: 10.1080/17474086.2019.1624519. Epub 2019 Jun 4. Expert Rev Hematol. 2019. PMID: 31130012 Review.
Perioperative hemostasis for patients with hemophilia.
Poston JN, Kruse-Jarres R. Poston JN, et al. Among authors: kruse jarres r. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):586-593. doi: 10.1182/hematology.2022000387. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485165 Free PMC article. No abstract available.
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF; A-LONG Investigators. Mahlangu J, et al. Blood. 2014 Jan 16;123(3):317-25. doi: 10.1182/blood-2013-10-529974. Epub 2013 Nov 13. Blood. 2014. PMID: 24227821 Free PMC article. Clinical Trial.
82 results